Oranda, Ramel L.

HRN: 22-41-82  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2023
AMPICILLIN 500MG (VIAL)
05/04/2023
05/10/2023
IV
305mg
Q6h
PCAP Severe
Waiting Final Action 
05/09/2023
MUPIROCIN 2%, 15G (TUBE)
05/09/2023
05/16/2023
TOPICAL
Apply On Affected Area
BID
Prophylaxis
Waiting Final Action 
05/09/2023
CEFUROXIME 750MG (VIAL)
05/09/2023
05/15/2023
IVT
200 Mg
Q8
PCAP C
Waiting Final Action 
05/09/2023
CEFUROXIME 750MG (VIAL)
05/09/2023
05/15/2023
IVT
200 Mg
Q8
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: